Tuesday, March 17, 2026

Tooth Loss Starts Here: Experts Warn of Soaring Gum Disease Case

Last year's top outpatient disease was gum disease, not the common cold. Proper brushing techniques for prevention are discussed.

THE GREATEST FANTASY: Lee’s New North Korea Plan Is All Talk, ZERO Solution

President Lee Jae Myung outlines goals for peaceful unification with North Korea, emphasizing dialogue, cooperation, and denuclearization.

DOOMSDAY Clock: US Target List Grows as Kim Finalizes New ICBM Capable of Hitting Washington D.C.

North Korea launched new hypersonic short-range ballistic missiles before the APEC summit, signaling military strength and testing new weaponry.

Tag: Growth

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

Dongkoo Bio&Pharma Invests 1 Billion KRW in GenomAndCompany: What This Means for ADC Drug Development

Dongkoo Bio&Pharma invests 1 billion KRW in Genome & Company to enhance antibody and ADC drug development strategies.

Ubicare Targets 80%+ Operating Profit Growth in 2026 — Here’s What’s Changing in Its EMR and Platform Play

Ubicare reported a 46% increase in operating profit for 2025, driven by optimized revenue structures and plans for AI solutions in 2026.

U.S. Buyers Push Hyundai’s Electrified Line to New Record

Hyundai Motor's eco-friendly vehicle sales in the U.S. surpass 1 million, led by hybrids, showing rapid growth in recent years.

A New Hair-Growth Pathway?: JW0061 Targets GFRA1 After 7.2x Organoid Results and a 39% Animal Boost

JW Pharmaceutical's hair loss treatment JW0061 gains FDA approval for clinical trials, promising innovative growth stimulation for men and women.

Hugel’s Record-Breaking 2025 Financials: How Botulax and HA Fillers Drive 14% Revenue Growth

Hugel reports record 2025 financials with strong sales in toxins, fillers, and cosmetics, focusing on global market expansion.

SK Biopharm’s 2026 Sales Meeting: Key Strategies for Senolamate’s Global Success

SK Biopharm's U.S. subsidiary held its annual sales meeting, focusing on growth strategies and collaboration for Cenobamate's success.

ST Pharm’s Record Growth: How RNA-Based Therapies Are Transforming the CDMO Market in 2026

ST Pharm reports record growth in oligonucleotide CDMO, driven by rising demand for RNA-based treatments for chronic diseases.

Wontek’s V-Laser Approved for Versatile Treatments in Vietnam: A Game-Changer for Aesthetic Clinics

Wontech secures medical device approval for its V-Laser in Vietnam, enhancing its product lineup and market presence in medical aesthetics.

Elanco’s Vision for 2030: Key Insights from CEO Jeffrey Simmons’ Visit to South Korea

Elanco CEO Jeffrey Simmons visited South Korea to discuss growth strategies, celebrate anniversaries, and emphasize employee partnership.

K-Beauty Boom: How Classys, Hugel, and Wontech are Expanding in Global Markets

The K-beauty industry is growing, leveraging strong manufacturing and R&D capabilities alongside the global spread of Hallyu.

Celltrion Gets Global IB Upgrades: Morgan Stanley Raises Target to $206.25 as New Biosimilars Lift Margins

Celltrion is expanding through biosimilars and new drug development, attracting global investor interest and raising target stock prices.

How thynC™ is Revolutionizing Patient Monitoring: Insights from Seers Technology’s Success

Seers Technology aims for global expansion, projecting overseas sales to match domestic by 2029, driven by its innovative AI healthcare solutions.

Unlocking the Secrets of Hugel’s 900 Million USD Revenue Goal: A Comprehensive Guide

Hugel aims for 900 billion KRW in U.S. sales by 2028, leveraging a hybrid sales model to capture significant market share.

Samsung Biologics Unveils Three-Pillar Growth Strategy: How Capacity, Portfolio, and Global Expansion Shape 2026

Samsung Biologics outlines a growth strategy focused on production, portfolio, and global expansion to enhance its CDMO position.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.